Advanced Filters
noise

diabetes Clinical Trials

A listing of diabetes medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,606 clinical trials
H Hugues PATURAL, MD PhD

Dysautonomia in Children With Type 1 Diabetes

Some physiological factors, such as physical activity, or pathological factors, such as sepsis or diabetes, are known to modulate the overall autonomic activity and the individual's intrinsic capacity to regulate their sympathetic and parasympathetic balance. These conditions can alter the physiological autonomic balance, sometimes with positive consequences on the FC-breathing …

1 - 17 years of age All Phase N/A

Mechanisms of Ultrasound Neuromodulation Effects in Diabetes

This study aims to evaluate the effect of hepatic ultrasound treatment on changes from baseline in whole-body insulin sensitivity during a hyperinsulinemic, euglycemic clamp (HE Clamp).

18 - 80 years of age All Phase N/A
F Frank Scheer, PhD

Can Food Timing Reduce Your Diabetes Risk?

The goal of this clinical trial is to test whether food timing impacts metabolic health in healthy participants. Participants will: complete 2 inpatient stays be provided with test meals have frequent blood draws

18 - 45 years of age All Phase N/A

Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes

This exploratory pilot study aims to evaluate the cognitive improvement effects of combination therapy with cilostazol (200 mg) and ginkgo biloba extract (160 mg) in elderly patients with type 2 diabetes mellitus. Both agents have demonstrated potential cognitive benefits through mechanisms such as enhanced cerebral blood flow, anti-inflammatory activity, and …

60 years of age All Phase 3

Exercise Training and Endothelial Function in Type 1 Diabetes

Endothelial dysfunction and vasoreactivity disorders are early subclinical complications of type 1 diabetes (T1D). In a preventive setting, in T1D patients still free of complications, the research of non-pharmacological interventions to improve endothelial function appears fundamental. In this randomized controlled trial, the effects of exercise training on endothelial function will …

18 - 50 years of age All Phase N/A
S Stephanie Griggs

Health Behavior Intervention for Adults With Type 1 Diabetes

Type 1 diabetes (T1D) affects approximately 2 million Americans, and only 2 in 8 young adults ages 18-31 years achieve glycemic targets (glycated hemoglobin A1C \<7.0%). Achieving glycemic targets is associated with reduced risk of micro-and macrovascular complications. Sleep deprivation leads to impaired glucose tolerance and insulin sensitivity in adults …

18 - 40 years of age All Phase N/A
G Gottfried Rudofsky, Prof.

Bicycle Exercise and Lifestyle Intervention in Newly Diagnosed Diabetes

The aim of the study is to test the efficacy, feasibility, and safety of a bicycle exercise followed by an intensive lifestyle intervention for 3 months in patients with recent onset and medically untreated type 2 diabetes.

18 years of age All Phase N/A
M Mirjam Christ-Crain, Prof. Dr. med.

Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus

This randomized, placebo-controlled, double-blind trial aims to investigate intranasal OXT as a novel therapeutical option in central diabetes insipidus (cDI) to improve psychological symptoms and socio-emotional functioning. Optionally, patients can present for additional assessments in sub-studies: fMRI sub-study at day 14 (± 2 days) (one additional visit) Social-stress sub-study at …

18 years of age All Phase 2
D Damien JOLLY

Advanced Glycation Products and Vascular Complications in Type 1 Diabetes

DIABAGE (Diabetes Advanced Glycation End products) study was conducted between 2015 and 2017. It included 196 type 1 diabetic patients with more than 10 years of diabetes. It revealed a significant association between the occurrence of vascular complications and tissular Advanced Glycation End products (AGEs) as well as with some …

18 years of age All Phase N/A
S Sheba

Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes

A Multiple Dose, Randomized, Placebo-controlled, Dose-escalating Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered MD-18 for healthy subjects with overweight or obesity

18 - 70 years of age All Phase 1

Simplify language using AI